• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-

Return to search Page to restart searchReturn to Orphan Designation Search PageReturn to Search Page
 
Generic Name:leukocyte interleukin
Trade Name:Multikine
Date Designated: 05-04-2007
Orphan Designation:Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck
Orphan Designation Status: Designated
FDA Orphan Approval Status:Not FDA Approved for Orphan Indication
CEL-SCI Corporation
8229 Boone Blvd.
Suite 802
Vienna, VA 22182

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-